Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,041.65
-23.70 (-2.22%)
At close: Aug 8, 2025
Exscientia Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 317,123 | 313,781 | 290,019 | 248,554 | 234,555 | 247,746 | Upgrade |
Other Revenue | 3,126 | 3,456 | - | - | - | - | Upgrade |
| 320,249 | 317,237 | 290,019 | 248,554 | 234,555 | 247,746 | Upgrade | |
Revenue Growth (YoY) | 7.76% | 9.38% | 16.68% | 5.97% | -5.33% | 7.26% | Upgrade |
Cost of Revenue | 131,928 | 130,262 | 129,857 | 116,417 | 104,499 | 101,898 | Upgrade |
Gross Profit | 188,321 | 186,975 | 160,162 | 132,137 | 130,056 | 145,849 | Upgrade |
Selling, General & Admin | 46,325 | 44,756 | 40,434 | 36,560 | 35,751 | 36,576 | Upgrade |
Other Operating Expenses | 76,103 | 76,164 | 60,894 | 58,083 | 49,976 | 54,183 | Upgrade |
Operating Expenses | 138,937 | 137,415 | 116,247 | 107,018 | 96,992 | 101,313 | Upgrade |
Operating Income | 49,384 | 49,560 | 43,915 | 25,119 | 33,064 | 44,536 | Upgrade |
Interest Expense | -4,440 | -4,572 | -2,681 | -1,290 | -368.4 | -595.7 | Upgrade |
Interest & Investment Income | - | - | 2,883 | 1,485 | 349.7 | 223.7 | Upgrade |
Earnings From Equity Investments | -283.8 | -316.9 | -171.6 | -116.7 | -312.5 | -553.6 | Upgrade |
Currency Exchange Gain (Loss) | -240.4 | -226.5 | 387.8 | - | 699.6 | 1,036 | Upgrade |
Other Non Operating Income (Expenses) | 4,705 | 5,851 | 1,672 | 974.6 | 1,028 | 1,521 | Upgrade |
EBT Excluding Unusual Items | 49,125 | 50,296 | 46,006 | 26,173 | 34,461 | 46,167 | Upgrade |
Merger & Restructuring Charges | - | - | -986.6 | - | - | - | Upgrade |
Impairment of Goodwill | - | - | -27.4 | -70.3 | - | -4,349 | Upgrade |
Gain (Loss) on Sale of Investments | 367 | 367 | 1 | - | 290.8 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 234.9 | 132.3 | -400.2 | -1,411 | Upgrade |
Asset Writedown | - | - | -2,834 | -239.6 | -1,922 | - | Upgrade |
Other Unusual Items | - | - | 1,407 | 130.1 | 1,298 | 33,029 | Upgrade |
Pretax Income | 49,492 | 50,663 | 43,800 | 26,125 | 33,727 | 73,436 | Upgrade |
Income Tax Expense | 15,597 | 15,827 | 12,110 | 6,849 | 7,256 | 20,098 | Upgrade |
Earnings From Continuing Operations | 33,895 | 34,836 | 31,690 | 19,277 | 26,471 | 53,338 | Upgrade |
Minority Interest in Earnings | 18.7 | 23.2 | 40 | -1.5 | 10.4 | 10.2 | Upgrade |
Net Income | 33,914 | 34,859 | 31,730 | 19,275 | 26,482 | 53,348 | Upgrade |
Net Income to Common | 33,914 | 34,859 | 31,730 | 19,275 | 26,482 | 53,348 | Upgrade |
Net Income Growth | -3.69% | 9.86% | 64.62% | -27.21% | -50.36% | 87.51% | Upgrade |
Shares Outstanding (Basic) | 582 | 583 | 586 | 586 | 586 | 586 | Upgrade |
Shares Outstanding (Diluted) | 582 | 583 | 586 | 586 | 586 | 586 | Upgrade |
Shares Change (YoY) | -0.74% | -0.53% | - | - | - | - | Upgrade |
EPS (Basic) | 58.32 | 59.81 | 54.15 | 32.90 | 45.20 | 91.05 | Upgrade |
EPS (Diluted) | 58.32 | 59.81 | 54.15 | 32.90 | 45.19 | 91.05 | Upgrade |
EPS Growth | -2.97% | 10.45% | 64.62% | -27.21% | -50.37% | 87.51% | Upgrade |
Free Cash Flow | - | 19,568 | -3,458 | -170.5 | 29,636 | 18,911 | Upgrade |
Free Cash Flow Per Share | - | 33.57 | -5.90 | -0.29 | 50.58 | 32.27 | Upgrade |
Dividend Per Share | - | - | 4.500 | 3.000 | 9.000 | 4.000 | Upgrade |
Dividend Growth | - | - | 50.00% | -66.67% | 125.00% | 33.33% | Upgrade |
Gross Margin | 58.80% | 58.94% | 55.23% | 53.16% | 55.45% | 58.87% | Upgrade |
Operating Margin | 15.42% | 15.62% | 15.14% | 10.11% | 14.10% | 17.98% | Upgrade |
Profit Margin | 10.59% | 10.99% | 10.94% | 7.75% | 11.29% | 21.53% | Upgrade |
Free Cash Flow Margin | - | 6.17% | -1.19% | -0.07% | 12.63% | 7.63% | Upgrade |
EBITDA | 66,570 | 66,054 | 57,641 | 36,344 | 43,114 | 53,947 | Upgrade |
EBITDA Margin | 20.79% | 20.82% | 19.88% | 14.62% | 18.38% | 21.77% | Upgrade |
D&A For EBITDA | 17,186 | 16,494 | 13,726 | 11,225 | 10,050 | 9,411 | Upgrade |
EBIT | 49,384 | 49,560 | 43,915 | 25,119 | 33,064 | 44,536 | Upgrade |
EBIT Margin | 15.42% | 15.62% | 15.14% | 10.11% | 14.10% | 17.98% | Upgrade |
Effective Tax Rate | 31.51% | 31.24% | 27.65% | 26.21% | 21.52% | 27.37% | Upgrade |
Revenue as Reported | 325,311 | 323,456 | 295,593 | 251,460 | 237,758 | 251,555 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.